Remarkably, in the TCGA-BLCA cohort, patients with suppression of DDR pathways exhibited a significant increase in the level of the TGF-β response (p=1.8e-8) (Figure 5D). The gene discussed is TGFB1; the disease is bladder transitional cell carcinoma.